Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zymeworks Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

5 Short Squeeze Candidates To Watch This Week: Aterian, Harbor Custom Development Remain At The Top, Veru Joins ↗

May 02, 2022

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value...

Via Benzinga

Zymeworks Announces Participation in Upcoming Investor Conferences

May 02, 2022

From Zymeworks Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 29, 2022

Via Benzinga

Why Is Zymeworks (ZYME) Stock Surging 30% Today? ↗

April 29, 2022

Zymeworks (ZYME) stock is taking off on Friday after the company revealed an unsolicited offer from private equity firm All Blue Falcons FZE.

Via InvestorPlace

Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points ↗

April 29, 2022

U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

70 Biggest Movers From Friday ↗

May 02, 2022

Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)...

Via Benzinga

The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid ↗

April 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

48 Stocks Moving In Friday's Mid-Day Session ↗

April 29, 2022

Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS. GTY Technology Holdings Inc. (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 29, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 29, 2022

Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday!

Via InvestorPlace

28 Stocks Moving in Friday's Pre-Market Session ↗

April 29, 2022

Gainers Zymeworks Inc. (NASDAQ: ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting of offer letter from Blue Falcons for $10.50 per...

Via Benzinga

Zymeworks Confirms Receipt of Unsolicited, Non-Binding Proposal from All Blue Falcons

April 28, 2022

From Zymeworks Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

April 28, 2022

During Thursday, 849 stocks hit new 52-week lows.

Via Benzinga

Zymeworks Reports Last Patient Enrolled in Pivotal Study of Zanidatamab in Treatment of HER2-Expressing Late-Line Biliary Tract Cancer

April 28, 2022

From Zymeworks Inc.

Via Business Wire

Zymeworks Announces Presentations at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

April 27, 2022

From Zymeworks Inc.

Via Business Wire

Zymeworks to Host First Quarter 2022 Results Conference Call

April 19, 2022

From Zymeworks Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

April 18, 2022

On Monday, 466 companies hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

HC Wainwright Sees 'Multiple Catalyst Opportunities' After Atreca Inks Licensing Pact With Zymeworks ↗

April 06, 2022

Via Benzinga

Good and Bad stock news ↗

April 05, 2022

Microsoft is down because of an FTC investigation of its possible anti-competitive moves.

Via Talk Markets

Zymeworks Announces Participation in Upcoming Investor Conferences

April 01, 2022

From Zymeworks Inc.

Via Business Wire

Flood Helping Ukraine ↗

March 24, 2022

Emerging markets are gaining as mature markets look risky.

Via Talk Markets

Up On Bad News ↗

March 22, 2022

Despite the plane crash in China, Boeing's stock is up today.

Via Talk Markets

Lucky Day ↗

March 21, 2022

Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund.

Via Talk Markets

World Markets News For Friday ↗

March 18, 2022

Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗

March 15, 2022

Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 08, 2022

Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 04, 2022

On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.